Partnership to Offer Comprehensive Biologics Testing Solutions

Beckman Coulter Genomics and Vitrology Ltd. announces a strategic partnership to offer customers a wide range of biosafety testing services. The alliance provides the biopharmaceutical industry with two inclusive sources for the full complement of molecular, in vitro and in vivo genomic services necessary for the identification, stabilization and purification of biological products.

The alliance also provides customers with access to the next generation sequencing technologies that are revolutionizing biology. It is widely recognized that massively parallel sequencing technologies hold incredible promise for the study of DNA sequence variation in vaccines, cell banks and gene therapy products, and allow the use of an open-question approach for the safety characterization of biologics.

“Partnering with leading-edge innovators to respond to the dynamic research needs of our customers worldwide is fundamental to our goals as a quality genomic services provider,” said Elena Jouravleva, global product manager for Biologics Testing Services at Beckman Coulter Genomics. “This alliance supplements Beckman Coulter’s existing biologics testing services, which have a focus on identity and stability testing, with Vitrology’s expertise in biosafety testing, in both Good Manufacturing Practice and Good Laboratory Practice environments.”

“We are pleased to partner with Beckman Coulter Genomics to offer the global biotechnology industry an array of scientific assays to fully characterize a wide range of biologics,” said Margaret Temple, CEO of Vitrology. “This dynamic new alliance is a natural fit, coupling Beckman Coulter Genomics’ sequencing and marketing capabilities with the experience of the Vitrology team to offer an expert source of safety testing with sequencing data and analysis. Both companies are committed to ensuring that they offer the appropriate range of assays to ensure clients can achieve regulatory authority approval for product safety.”

Beckman Coulter Genomics provides Sanger and next generation DNA sequencing, gene expression profiling, genotyping and biologics testing services. The collaboration between Beckman Coulter Genomics and Vitrology further expands and complements both companies’ extensive biologics testing services portfolios, which are available to clients worldwide.